A groundbreaking study reveals that new cardiovascular risk equations could significantly decrease the number of middle-aged adults eligible for aspirin to prevent heart disease, raising questions about current guidelines and the safety of aspirin use.
A groundbreaking new pill, Obicetrapib, has shown promise in drastically lowering LDL cholesterol and lipoprotein(a), offering hope to patients at high risk of heart disease and stroke.
New research reveals that simple changes like replacing sedentary time with light activity can drastically reduce the risk of a second heart attack. Discover how to protect your heart with easy lifestyle adjustments!
